“The data on the third dose” of the anti covid vaccine “coming from Israel are very interesting and have been published in one of the most prestigious scientific journals in the world. With the third dose, subjects over 60 years old have a return to efficacy 95% original, the same as it was at the beginning before the Delta arrived and the serious disease rate is 19.5 times lower. for serious pathology. So the third dose is welcome in the most fragile people “. So at Adnkronos Salute Matteo Bassetti, director of the Infectious Diseases Clinic of the Policlinico San Martino in Genoa, comments on the first findings from vaccination with the third dose of the Pfizer-BionTech vaccine.